TELEFLEX INC's ticker is TFX and the CUSIP is 879369106. A total of 283 filers reported holding TELEFLEX INC in Q3 2014. The put-call ratio across all filers is 11.54 and the average weighting 0.2%.
About TELEFLEX INC
Teleflex Inc. is a global provider of medical technologies that are designed to improve patient outcomes and enhance healthcare provider productivity. The company's products are used in a wide range of medical procedures, including vascular access, respiratory care, anesthesia, and surgery.
Teleflex has a strong reputation for innovation, with a focus on developing products that are both effective and easy to use. The company's portfolio includes a number of market-leading products, such as the Arrow® EZ-IO® Intraosseous Vascular Access System, which is used to provide rapid vascular access in emergency situations.
In addition to its medical technologies business, Teleflex also has a presence in the commercial and military aerospace industries. The company's aerospace division provides a range of products and services, including control systems, fuel systems, and landing gear.
Teleflex has a strong financial position, with a market capitalization of over $16 billion as of August 2021. The company has a solid track record of revenue growth, with sales increasing by 10% in the second quarter of 2021 compared to the same period in the previous year.
Overall, Teleflex is a well-established and innovative company that is well-positioned to continue delivering strong results in the medical technologies and aerospace industries. Investors looking for exposure to these sectors may want to consider adding Teleflex to their portfolios.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $432,028,000 | -3.0% | 2,230,068 | -19.3% | 0.35% | -5.9% |
| Q4 2016 | $445,520,000 | +31.0% | 2,764,584 | +36.6% | 0.38% | +30.7% |
| Q3 2016 | $340,075,000 | -13.3% | 2,023,652 | -8.5% | 0.29% | -13.8% |
| Q2 2016 | $392,312,000 | +12.5% | 2,212,587 | -0.4% | 0.33% | +9.9% |
| Q1 2016 | $348,849,000 | +38.2% | 2,221,811 | +15.7% | 0.30% | +40.9% |
| Q4 2015 | $252,512,000 | -15.9% | 1,920,973 | -20.5% | 0.22% | +59.3% |
| Q3 2015 | $300,280,000 | +641.4% | 2,417,512 | +708.5% | 0.14% | +309.1% |
| Q2 2015 | $40,501,000 | +401.0% | 299,011 | +347.0% | 0.03% | +371.4% |
| Q1 2015 | $8,084,000 | -20.3% | 66,900 | -24.2% | 0.01% | -22.2% |
| Q4 2014 | $10,139,000 | +2.1% | 88,300 | -6.6% | 0.01% | 0.0% |
| Q3 2014 | $9,926,000 | +0.9% | 94,500 | +1.4% | 0.01% | 0.0% |
| Q2 2014 | $9,842,000 | +64.2% | 93,200 | +66.7% | 0.01% | +50.0% |
| Q1 2014 | $5,995,000 | +5.9% | 55,900 | -7.3% | 0.01% | +20.0% |
| Q4 2013 | $5,660,000 | -15.6% | 60,300 | -26.0% | 0.01% | -28.6% |
| Q3 2013 | $6,706,000 | +5.2% | 81,500 | -1.0% | 0.01% | 0.0% |
| Q2 2013 | $6,377,000 | – | 82,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kimelman & Baird, LLC | 124,067 | $32,069,000 | 4.99% |
| VILLERE ST DENIS J & CO LLC | 230,443 | $59,564,000 | 4.20% |
| ATLANTA CAPITAL MANAGEMENT CO L L C | 2,632,482 | $680,444,000 | 3.77% |
| MAR VISTA INVESTMENT PARTNERS LLC | 331,422 | $85,666,000 | 2.88% |
| FAIRVIEW CAPITAL INVESTMENT MANAGEMENT, LLC | 186,469 | $48,198,000 | 2.87% |
| STONE RUN CAPITAL, LLC | 17,820 | $4,606,000 | 2.87% |
| MOUNTAIN PACIFIC INVESTMENT ADVISERS LLC | 90,075 | $23,283,000 | 2.60% |
| Drexel Morgan & Co. | 10,000 | $2,585,000 | 2.58% |
| Select Equity Group, L.P. | 1,126,594 | $291,202,017,000 | 2.20% |
| Red Cedar Capital, LLC | 7,667 | $1,982,000 | 1.92% |